Supplementation of Infant Formula with Probiotics, Prebiotics, DHA & ARA: A Systematic Review
There are recommendations to guide parents to help their infants make the transition from milk to weaning foods, but they differ in their focus in developed or developing countries and on the physiological and behavioral reasons that underlie the introduction of weaning foods. According to recommendations, ideally, term infants should begin weaning at six months, while breastfeeding should continue for two years. The recommendations on nutrients in complementary foods are based on the nutrient gap between the composition and volume of breast milk after approximately six months of exclusive breastfeeding and the physiology of infant nutritional requirements. Gastrointestinal flora influences health, but the composition of flora can be changed with prebiotics or probiotics. The addition of probiotics to powdered infant formula has not been demonstrated to be harmful to healthy term infants. ESPGHAN Committee on Nutrition reviews the effect of adding probiotic bacteria to infant formulas, follow-on formulas and special medical foods. The administration of probiotic (single or in combination) supplementation in infant or follow-on formula, and given beyond early infancy, may be associated with some clinical benefits, such as a reduction in the risk of nonspecific gastrointestinal infections, a reduced risk of antibiotic use and a lower frequency of colic and irritability. The addition of prebiotics to infant formula softens stools but other putative effects remain to be demonstrated. Studies published post marketing shows that infant fed a long-chain inulin/galactooligosaccharide mixture (0.8 g/dl) in formula normally have no side – effects. The addition of same mixture at a concentration of 0.8 g/dl to infant formula was therefore recognized as safe by European Commission in 2001 but follow – up studies were recommended. It is thought that a bifidogenic effect is beneficial for the infant host. The rising incidence in allergy during the first year of life may justify the attempts to modulate the infant’s formula. In addition to prebiotic and probiotic, DHA and ARA are important for brain and eye development. Many researchers have demonstrated the role of DHA and ARA in infant health and development.
Tambakhe M. K.,
Pawar P. A.,
Supplementation of Infant Formula with Probiotics, Prebiotics, DHA & ARA: A Systematic Review, Journal of Food and Nutrition Sciences.
Vol. 2, No. 4,
2014, pp. 185-194.
A.C. Uwaegbute, and D.O. Nndnyehtgo, “Differences in the infant-feeding practices in urban and rural Nigeria. Journal of Nutritional Education”, 1987, vol. 19, pp.83-89.
A.K. Dutta-Roy, “Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta”, Am J Clin Nutr, 2000, vol. 71, pp.315S-22S.
A.P. Simopoulos, “Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids”, J Am Coll Nutr, 1999, vol. 18(5), pp. 487-9.
Association of Official Agricultural Chemists (AOAC). Official methods of the Association of Official Agricultural Chemists (AOAC) international, 17th Edition. 2002.
B. Koletzko, E. Lien and C. Agostoni, “The roles of long- chain polyunsaturated fatty acids in pregnancy, lactation and infancy”, Review of current knowledge and consensus recommendations.J Perinat Med 2008, vol. 36, pp.5-14.
B. Koletzko,” Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group”, J Pediatr Gastroenterol Nutr 2005, vol. 41, pp.584-99.
B. Koletzko, “Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatr”, 2001, pp. 90-460.
C. Agostoni, E. Riva, M. Giovannini, Complementary food: international, comparison on protein and energy requirements/intakes. Nestle Nutr Workshop Ser Pediatr Program. 2006, vol. 58, pp.147-156, discussion pp.156-159.
C. Agostoni, “Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice”, the role of long-chain polyunsaturated fatty acids. Pediatr Res, 1995, pp. 38-262.
C. Agostoni, I. Axelsson and C. Braegger, “Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition”, J Pediatr Gastroenterol Nutr. 2004, vol. 38(4), pp.365-374.
C. Agostoni, T. Decsi and M. Fewtrell, “Medical position paper on complementary feeding: a commentary by the ESPGHAN Committee on Nutrition”, J Pediatr Gastroenterol Nutr. 2008, vol. 46(1), pp.99-110.
C. Braegger, A. Chmielewska and T. Decsi, “Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition”, J Pediatr Gastroenterol Nutr. 2011, vol. 52(2), pp. 238-250.
C.W. Van Niel, C. Feudtner, MM. Garrison and DA. Christakis, “Lactobacillus therapy for acute infectious diarrhea in children”, a meta-analysis. Pediatrics. 2002, vol. 109(4), pp.678-684.
D.A. Osborn and J.K. Sinn, “Prebiotics in infants for prevention of allergic disease and food hypersensitivity”, [Cochrane review]. In The Cochrane Library, Issue 4, 2007. Oxford: Update Software.
D.A Osborn and J.K, Sinn, “Probiotics in infants for prevention of allergic disease and food hypersensitivity”, [Cochrane review]. In The Cochrane Library, Issue 4, 2007. Oxford: Update Software.
Dietary reference intakes for calcium, phosphorous, magnesium, Vitamin D, and fluoride (1997); dietary reference intakes for thiamin, riboflavin, niacin, Vitamin B6, folate, Vitamin B12, pantothenic acid, biotin and choline (1998); dietary reference intakes for Vitamin C, Vitamin E, selenium and carotenoids (2000); dietary reference intakes for Vitamin A, Vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc (2001); dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids (2002/2005); and dietary reference intakes for calcium and Vitamin D (2011). USDA [homepage on the Internet]. c2012. Available from: http://fnic.nal.usda.gov/dietary-guidance/dietary-reference-intakes/dri-tables.
D.L. O’Connor, “Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics”, 2001, vol. 108(2), pp.359-71.
D.M. Stephenson, J.M. Gardner, S.P. Walker and A. Ashworth, “Weaning-food viscosity and energy density: their effects on ad libitum consumption and energy intakes in Jamaican children”, Am J Clin Nutr. 1994, vol. 60(4), pp.465-469.
D.R. Hoffman, “Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids”, J Pediatr Gastroenterol Nutr 2006, vol. 42, pp.287-292.
D.R. Hoffman, “Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months”, a randomized clinical trial. J Pediatr, 2003, vol. 142, pp.669-77.
D.W. Thomas and F.R. Greer, “Probiotics and prebiotics in pediatrics”, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Pediatrics. 2010, vol. 126(6), pp.1217-1231.
E.E. Birch, “A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants”, Dev Med Child Neurol, 2000, vol. 42(3): pp.174-81.
E.E. Birch, “A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 weeks of age”, Am J Clin Nutr, 2002, vol. 75, pp.570-80.
E.E. Birch, “Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula”, Early Hum Dev (Epub), 2007.
E.E. Birch, “Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants”, Pediatr Res, 1998, vol. 44(2), pp.201-9.
E.E. Birch, “Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 month”, Am J Clin Nutr, 2005, vol. 81, pp.871-9.
European Food Safety Authority Panel on Dietetic Products, Nutrition and Allergies, “Scientific opinion on the appropriate age for introduction of complementary feeding of infants”, EFSA Journal. 2009, vol. 7(12), 1423.
F. Megraud, G. Boudraa, K. Bessaoud, S. Bensid, F. Dabis, R. Soltana and M. Touhami, “Incidence of Campylobatter infection in infants in western Algeria and the possible protective role of breast feeding”, Epidemiology and Infections 1990, vol. 105, pp.13-78.
Food and Agriculture Organisation of the United Nations and the World Health Organization. “Lipids in early development”, In: fats and Oils. Food and Nutrition Paper ISBN 92-5-103621-7 Chap. 7, 1993, pp.49-55. http://www.fao.org/docrep/V4700E/V4700E00.htm
G. Boehm and G. Moro, “Structural and functional aspects of prebiotics used in infant nutrition”, J Nutr. 2008, vol. 138(9), pp.1818S-1828S.
G. Kohn, “Diet and essential fatty acid status of term infants”, Acta Paediatr Suppl, 1994, vol. 402, pp.69-74.
G. Veereman-Wauters, “Application of prebiotics in infant foods”, Br J Nutr. 2005, vol. 93(Suppl 1), pp. S57-S60.
H. Parracho, A.L. McCartney and G.R. Gibson. “Probiotics and prebiotics in infant nutrition”, Proc Nutr Soc. 2007, vol. 66(3), pp.405-411.
H. Szajewska, J.Z. Mrukowicz, “Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children”, a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001, vol.33 (Suppl 2), pp.S17-S25.
H. Szajewska, M. Ruszczynski and A. Radzikowski. “Probiotics in the prevention of antibiotic-associated diarrhea in children”, a meta-analysis of randomized controlled trials. J Pediatr. 2006, vol. 149(3), pp.367-372.
J. Chouraqui, D. Grathwohl and J. Labaune, “Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial”, Am J Clin Nutr. 2008, vol. 87(5), pp.1365-1373.
J. Dobbing and J. Sands, “Quantitative growth and development of the human brain”, Arch Dis Child 1973, vol. 48, pp.757-67.
J. Van der Merwe, M. Kluyts, N. Bowley and M. Marais, “Optimizing the introduction of complementary foods in the infant’s diet: a unique challenge in developing countries”, Matern Child Nutr. 2007, vol. 3(4), pp.259-270.
J. Vanderhoof, “Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptual age”, J Pediatr Gastroenterol, 1999, vol. 29, pp.318-26.
J. Vanderhoof, “A multicenter long-term safety and efficacy trial of preterm formula supplemented with long-chain polyunsaturated fatty acids”, for The Multicenter Study Group. J Pediatr Gastroenterol Nutr, 2000, vol. 31(2), pp.121-7.
J. Waterlow and P.R. Payne, “The protein gap”, Nature 1975, vol. 258, pp.113-117.
J. Waterlow. “Observations on the suckling’s dilemma-a personal view”, Journal of Human Nutrition 1981, vol. 35, pp.85-98.
J.A. Lanigan, J.A. Bishop, A.C. Kimber and J. Morgan Systematic review concerning the age of introduction of complementary foods to the healthy full-term infant. Eur J Clin Nutr. 2001, vol. 55(5), pp.309-320.
J.E. Kimmons, K.G. Dewey and E. Haque, “Behavior-change trials to assess the feasibility of improving complementary feeding practices and micronutrient intake of infants in rural Bangladesh”, Food Nutr Bull. 2004, vol. 25(3), pp.228-238.
J.M. Saavedra, A. Abi-Hanna, N. Moore and R.H. Yolken, “Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety”, Am J Clin Nutr. 2004, vol. 79(2), pp.261-267.
J.M. Saavedra, “Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects”, Nutr Clin Pract. 2007, vol. 22(3), pp.351-365.
J.S. Forsyth, “Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood”, follow up of a randomised controlled trial. BMJ, 2003, vol. 326(7396), pp.953.
J.S. Huang, A. Bousvaros and J.W. Lee, “Efficacy of probiotic use in acute diarrhea in children: a meta-analysis”, Dig Dis Sci. 2002, vol. 47(11), pp.2625-2634.
K.D. Foote and L.D. Marriott. “Weaning of infants”, Arch Dis Child. 2003, vol. 88(6), pp. 488-492.
K.G. Dewey, R.J. Cohen and N.G. Rollings. WHO technical background paper: “feeding of nonbreastfed children from 6 to 24 months of age in developing countries”, Food and Nutr Bull. 2004, vol. 25(4), pp.377-402.
K.H. Brown, “Breastfeeding and complementary feeding of children up to 2 years of age”, Nestle Nutr Workshop Ser Pediatr Program. 2007, vol. 60, pp.1-10; discussion 10-3.
L. Lauritzen, “The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina”, Prog Lipid Res, 2001, vol. 40, pp.1-94.
M. Fewtrell, A. Lucas and J.B. Morgan, “Factors associated with weaning in full term and preterm infants”, Arch Dis Child Neonatal Ed. 2003, vol. 88(4), pp.F296-F301.
M. Makrides, “Are long-chain polyunsaturated fatty acids essential nutrients in infancy? “, Lancet, 1995, vol. 345 (8963), pp.1463-8.
M. Makrides, “Fatty acid composition of brain, retina, and erythrocytes in breast-fed and formula-fed infants”, Am J Clin Nutr, 1994, vol. 60(2), pp.189-94.
M. Martinez, “Tissue levels of polyunsaturated fatty acids during early human development”, Pediatr, 1992, vol. 120, pp. S129-38.
M.A. Crawford, “The role of essential fatty acids in neural development: implications for perinatal nutrition”, Am J Clin Nutr, 1993, vol. 57, pp.703S-709S.
M.S. Fewtrell, “Long-chain polyunsaturated fatty acids in early life: effects on multiple health outcomes”, a critical review of current status, gaps and knowledge. Nestle Nutr Workshop Ser Pediatr Program. 2006, vol. 57, pp.203-14; discussion 215 -2 21.
M.T. Clandinin, “Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid’, J Pediatr 2005, vol. 146, pp.461-8.
M.T. Clandinin, “Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements”, Early Hum Dev, 1980, vol. 4, pp. 121-9.
N. Jr. Salem, “Mechanisms of action of docosahexaenoic acid in the nervous system”, Lipids, 2001, vol. 36, pp.945-59.
N. Pastor, “Infants fed docosahexaenoic acid- and arachidonic acid-supplemented formula have decreased incidence of bronchiolitis bronchitis the first year of life”, Clin Pediatr (Phila), 2006, vol. 45(9), pp.850-5.
N.F. Butte, M.G. Lopez-Alarcon and C. Garza. ‘Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life”, Geneva: WHO; 2002.
P. Willatts, “Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age”, Lancet, 1998, vol. 352(9129), pp.688-91.
P.J. Aggett, “Feeding preterm infants after hospital discharge”, a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2006, vol. 42, pp.596-603.
R. Srinivasjois, S. Rao and S. Patole, “Prebiotic supplementation of formula in preterm neonates”, a systematic review and meta-analysis of randomised controlled trials. Clin Nutr. 2009, vol. 28(3), pp.237-242.
R. Yuhas, “Human milk fatty acid composition from nine countries varies most in DHA”, Lipids 2006, vol. 41, pp.851-8.
S. Arslanoglu, G.E. Moro and Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007, vol. 137(11), pp.2420-2424.
S. Gidding, B.A. Dennison and M.D. Cochair, “Recommendations for children and adolescents: a guide for practitioners”, Pediatrics. 2005, vol. 117(2), pp.544-559.
S. Rao, R. Srinivasjois and S. Patole, “Prebiotic supplementation in full-term neonates”, a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med. 2009, vol. 163(8), pp.755-764.
S.A. Sullivan and L.L. Birch, “Infant dietary experience and acceptance of solid food”, Pediatrics. 1994, vol. 93(2), pp.271-277.
S.E. Carlson, “Visual acuity and fatty acid status of term infants fed human milk and formulas with or without docosahexaenoate and arachidonate from egg yolk lecithin”, Pediatr Res, 1996, vol. 39, pp.882-8.
S.E. Morale, “Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity”, Early Hum Dev, 2005, vol. 81(2), pp.197-203.
S.J. Allen, B. Okoko and E. Martinez, “Probiotics for treating infectious diarrhoea”, [Cochrane review]. In The Cochrane Library, Issue 2, 2004. Oxford: Update Software.
S.M. Innis, “Blood lipid docosahexaenoic and arachidonic acid in term gestation infants fed formulas with high docosahexaenoic acid, low eicosapentaenoic acid fish oil”, Lipids, 1996, vol. 31, pp.617-25.
S.S. Gidding, B.A. Dennison and L.L. Birch, “Recommendations for children and adolescents”, a guide for practitioners. Pediatrics. 2005, vol. 117(2), pp.555-559.
T. Decsi and B. Koletzko, “Growth, fatty acid composition of plasma lipid classes, and plasma retinol and alpha-tocopherol concentration in full-term infants fed formula enriched with omega-6 and omega-3 long-chain polyunsaturated fatty acids”, Acta Paediatr, 1995, vol. 84(7), pp.725-32.
The Commission of the European Communities. Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC. Off J EU, Dec. 30, 2006:L401/1-33.
WHO. Feeding the non-breastfed child 6-24 months of age. Geneva: World Health Organization; 2004.
WHO. Guiding principles for complementary feeding of the breastfed child. Geneva: WHO; 2004.
World Health Organization. Global strategy for infant and young child feeding: the optimal duration of exclusive breastfeeding. 54th World Health Assembly; 2001.
World Health Organization/United Nations Children’s Fund. Global strategy for infant and young child feeding. Geneva: WHO; 2003.